Market Capitalization of Goldline Pharmaceutical Ltd
Goldline Pharmaceutical Ltd
NSE: GLPL
Market Cap
Key Highlights
- The Market Cap of Goldline Pharmaceutical Ltd is ₹ 39.33 crore as of 21 Aug 26 The Latest Trading Price of Goldline Pharmaceutical Ltd is ₹ 40.97 as of 21 Aug 15:30 .
Goldline Pharmaceutical Ltd
NSE: GLPL
Share Price
Market Price of Goldline Pharmaceutical Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 21 Aug 2026 | 40.97 |
| 20 Aug 2026 | 41.19 |
| 19 Aug 2026 | 39 |
| 18 Aug 2026 | 40.09 |
| 13 Aug 2026 | 40.09 |
| 12 Aug 2026 | 40.9 |
| 11 Aug 2026 | 40.5 |
| 10 Aug 2026 | 41.24 |
| 07 Aug 2026 | 42 |
| 06 Aug 2026 | 41.21 |
BlinkX Score for Goldline Pharmaceutical Ltd
Asset Value vs Market Value of Goldline Pharmaceutical Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Goldline Pharmaceutical Ltd
Historical P/E Ratio of Goldline Pharmaceutical Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Goldline Pharmaceutical Ltd
Historical Revenue of Goldline Pharmaceutical Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Goldline Pharmaceutical Ltd
Historical EBITDA of Goldline Pharmaceutical Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Goldline Pharmaceutical Ltd
Historical Net Profit of Goldline Pharmaceutical Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Goldline Pharmaceutical Ltd
Dividend Payout Over Time
About Goldline Pharmaceutical Ltd
- Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai.
- Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f.
- September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.
- Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente.
- The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company.
Goldline Pharmaceutical Ltd News Hub
Goldline Pharmaceutical to convene AGM
Goldline Pharmaceutical announced that the Annual General Meeting(AGM) of the company will be held o
Read more
07 Aug 26
BSE SME Goldline Pharmaceutical delivers a dose of listing gains
The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stoc
Read more
19 May 26
Goldline Pharmaceutical to discuss results
Goldline Pharmaceutical will hold a meeting of the Board of Directors of the Company on 9 June 2026.
Read more
03 Jun 26
